FDA 483 - Pinnacle Biologics Inc - June 27, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Pinnacle Biologics Inc, a specification developer in Bannockburn, IL, received a Form 483 for deficiencies in its medical device reporting and complaint handling procedures. The firm failed to submit Medical Device Reports (MDRs) within the required 30-day timeframe and did not adequately evaluate or investigate complaints, particularly those related to its Photodynamic Therapy (PDT) combination product. These issues indicate a lack of robust quality system controls for post-market surveillance.
ID · e6d5679e-d683-4a33-b634-2ddc38c379cf